Steven Camp oversees the program to ensure patient safety and efficacy Personalized treatment to suit your unique needs and goals Weekly follow up with a dedicated support team to ensure long-term success What Is the Difference Between the Types of GLP-1 Medications
IGF-DES Receptor Binding Specificity Competitive binding and receptor cross-linking experiments confirmed that both IGF-1 and des-(1-3)IGF-1 bind exclusively to the type 1 IGF receptor in L6 myoblasts, rat vascular smooth-muscle cells, and human lung fibroblasts with des-(1-3)IGF-1 demonstrating greater apparent potency in these assays, attributable to its low affinity for the competing 38 kDa IGFBP rather than differences in intrinsic receptor affinity
GLP-1 medications require a prescription and should be used only under the guidance of a licensed healthcare professional
This is because overseas manufacturers and suppliers operate outside Australian jurisdiction, and therefore cannot be compelled to comply with the Therapeutic Goods Act 1989 (Cth) or any other Australian therapeutic goods legislation. New regulations in New Zealand In May 2026, the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) issued a formal consumer advisory warning New Zealanders against purchasing or using unapproved synthetic peptides and Selective Androgen Receptor Modulators (SARMs) promoted online
Overview of Diabetes and Its Complications The prevalence of diabetes has been increasing exponentially, both in developing and developed nations
